Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 is shown on the page, and the disease term 'Multiple myeloma' and related topics such as 'MedlinePlus Genetics' were removed from the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section listing study sites across multiple states and updated the page revision to v3.3.3.SummaryDifference0.7%

- Check32 days agoChange DetectedThe page now includes related topic links to Multiple myeloma and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics from the page.SummaryDifference0.1%

- Check54 days agoChange DetectedPublication section now states that PubMed publications are automatically filled from PubMed, and a new Revision: v3.3.2 was added. The previous PubMed-origin description indicating automatic creation by PubMed with an NCT identifier was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the study page. Removed the government funding status notice.SummaryDifference0.3%

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.